Bevacizumab and convulsion 
Bevacizumab and convulsion Patient Reports February 10, 2012
Bevacizumab Side Effects Report #5985124-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 26, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, unevaluable event. Bevacizumab dosage: 498 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, BENDROFLUAZIDE, METOCLOPRAMIDE, LANSOPRAZOLE, ASPIRIN, SENOKOT, DEXAMETHASONE. Patient recovered.
Bevacizumab Side Effects Report #5989450-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 26, 2008. Female patient was diagnosed with ovarian epithelial cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, syncope. Bevacizumab dosage: 498 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, BENDROFLUAZIDE, METOCLOPRAMIDE, LANSOPRAZOLE, ASPIRIN, SENOKOT, DEXAMETHASONE. Patient recovered.
Bevacizumab Side Effects Report #4780308-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2005. Female patient, 59 years of age, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium abnormal, blood phosphorus decreased, cerebral infarction, chest x-ray abnormal, convulsion, haematocrit decreased, haemoglobin decreased, heart rate increased, hydronephrosis. Bevacizumab dosage: 825 MG, Q3W, INTRAVENOUS. Patient was hospitalized. Patient died on 08/02/2005.
Bevacizumab Side Effects Report #4780314-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 09, 2005. Female patient, 59 years of age, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: blood magnesium increased, blood phosphorus decreased, contrast media reaction, convulsion, disease progression, haematocrit decreased, haemoglobin decreased, heart rate increased. Bevacizumab dosage: 825 MG, Q3W, INTRAVENOUS. During the same period patient was treated with NIFEDIPINE, PAXIL, NEUTRA, MAGNESIUM SULPHATE, LACTULOSE, MEGACE, PRILOSEC, CIPROFLOXACIN. Patient was hospitalized. Patient died on 08/02/2005.
Bevacizumab Side Effects Report #5599815-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2008. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, convulsion, hydronephrosis, inadequate analgesia, malignant neoplasm progression, sepsis . Bevacizumab dosage: 10 MG/KG INTRAVENOUS DRIP. During the same period patient was treated with TOPOTECAN GSK, ACETAMINOPHEN, BISCODYL, DILAUDID, BUPIVACAINE, EPIDURAL, DIPHENHYDRAMINE, ERTAPENEM. Patient died on 01/09/2008.Bevacizumab Side Effects Report #5143788-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Nov 01, 2006. Male patient, 66 years of age, weighting 219.0 lb, was diagnosed with osteitis deformans and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, hypertension, mental status changes, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 1500MG Q3WKS IV. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4967125-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2006. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis, blood pressure increased, confusional state, convulsion, hypertension, hypertensive encephalopathy, hypokalaemia, malignant neoplasm progression. Bevacizumab dosage: unknown. During the same period patient was treated with PACILTAXEL, ACETAMINOPHEN, LABETALOL, ROCEPHIN, TOPROL, LISINOPRIL, AMPICILLIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5475146-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 19, 2007. Female patient, weighting 129.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 885 MG, Q3W. During the same period patient was treated with ATENOLOL, FLECAINIDE ACETATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5480932-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 24, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 870 MG, Q3W. During the same period patient was treated with GEMCITABINE, CISPLATIN. Patient was hospitalized. Patient died on 09/21/2007.
Bevacizumab Side Effects Report #5484346-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 03, 2007. Female patient, weighting 129.6 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 885 MG, Q3W. During the same period patient was treated with ATENOLOL, FLECAINIDE ACETATE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5508345-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 23, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 870 MG, Q3W. During the same period patient was treated with GEMCITABINE, CISPLATIN, MORPHINE, CLONIDINE. Patient was hospitalized. Patient died on 09/21/2007.
Bevacizumab Side Effects Report #5635326-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 15, 2008. Male patient, weighting 248.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, loss of consciousness, malignant neoplasm progression, neuropathy peripheral, renal failure acute, tumour haemorrhage, visual field defect. Bevacizumab dosage: 1656 MG, Q3W. During the same period patient was treated with CISPLATIN, DOCETAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5645609-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2008. Male patient, weighting 248.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 1656 MG, Q3W. During the same period patient was treated with CISPLATIN, DOCETAXEL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5951659-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CISPLATIN, VIANI, LEVOTHYROXINE, SPIRIVA, THEOPHYLLINE, VOLTAREN, PANTOZOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5988832-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 26, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CISPLATIN, VIANI, LEVOTHYROXINE, SPIRIVA, THEOPHYLLINE, VOLTAREN, PANTOZOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5490450-7
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 17, 2007. Female patient, 61 years of age, weighting 162.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute sinusitis, blood pressure increased, convulsion, dyskinesia, eye rolling, foaming at mouth, meningitis
, reversible posterior leukoencephalopathy syndrome, urinary incontinence . Bevacizumab dosage: 710 MG Q 2 WEEKS IV. During the same period patient was treated with ALDESLEUKIN, SILVADENE, OYCONDONE, OXYCONTIN, MEGACE, LOVENOX, AMBIEN, PHENERGAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5140357-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Male patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 100 MG EVERY 3 WEEKS. During the same period patient was treated with ATENOLOL, VITAMIN CAP, XANAX, PREVACID, DOXAZOSIN MESYLATE, OTERACIL POTASSIUM, GIMERACIL, TEGAFUR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5156251-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Male patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, nausea
, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 100 MG EVERY 3 WEEKS. During the same period patient was treated with ATENOLOL, VITAMIN CAP, XANAX, PREVACID, DOXAZOSIN MESYLATE, OTERACIL POTASSIUM, GIMERACIL, TEGAFUR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5179363-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Male patient, 65 years of age, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, nausea
, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 100 MG EVERY 3 WEEKS. During the same period patient was treated with ATENOLOL, VITAMIN CAP, XANAX, PREVACID, DOXAZOSIN MESYLATE, OTERACIL POTASSIUM, GIMERACIL, TEGAFUR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5733376-3
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on May 01, 2008. Female patient, 30 years of age, weighting 94.80 lb, was diagnosed with metastatic gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 7.5 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, FLUOROURACIL, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5580536-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 31, 2007. Male patient, weighting 189.4 lb, was diagnosed with malignant glioma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 10 MG/K Q 2 WEEKS IV. During the same period patient was treated with ETOPOSIDE, PAXIL, KEPPRA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5736177-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 09, 2008. Female patient, 48 years of age, weighting 127.9 lb, was diagnosed with head and neck cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, disorientation, hypertension, leukoencephalopathy, nausea , tonic clonic movements, visual disturbance. Bevacizumab dosage: 614 MG, Q 2 WKS, IV. During the same period patient was treated with CISPLATIN, TARCEVA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5710454-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 10, 2008. Female patient, 49 years of age, was diagnosed with glioma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, pericardial effusion, pulmonary embolism
. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ENZASTAURIN, KEPPRA, EPINEPHRINE. Patient died on 03/25/2008.Bevacizumab Side Effects Report #5812260-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 08, 2008. Female patient, 49 years of age, was diagnosed with glioma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest
, cardiopulmonary failure, cephalhaematoma, convulsion, electromechanical dissociation, fall , head injury, hypotension. Bevacizumab dosage: unknown. During the same period patient was treated with ENZASTAURIN, KEPPRA, DILANTIN, PROTONIX, DECADRON, BACTRIM, WELLBUTRIN. Patient died on 03/25/2008.Bevacizumab Side Effects Report #5173443-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 08, 2006. Female patient, weighting 119.3 lb, was diagnosed with glioma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia
, convulsion, disease progression, hemiparesis, mental status changes, pyrexia, refusal of treatment by patient, refusal of treatment by relative, urinary incontinence . Bevacizumab dosage: 566MG QOW IV. During the same period patient was treated with IRINOTECAN, HYDROCHLOROTHIAZIDE, DEXAMETHASONE, ACIPHEX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5902515-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 15, 2008. Male patient, 67 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE, CORTICOSTEROIDS. Patient recovered.
Bevacizumab Side Effects Report #5904015-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 15, 2008. Female patient, 60 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, deep vein thrombosis
, hypertension, pulmonary embolism . Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5178861-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 27, 2006. Male patient, 58 years of age, weighting 200.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, malaise. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient died on 11/24/2006.
Bevacizumab Side Effects Report #5189686-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 30, 2006. Male patient, 58 years of age, weighting 200.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, depression
, malaise. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient died on 11/24/2006.Bevacizumab Side Effects Report #5189688-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2006. Male patient, 58 years of age, weighting 200.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, depression
, malaise. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient died on 11/24/2006.Bevacizumab Side Effects Report #5211328-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2007. Male patient, 57 years of age, weighting 190.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5232142-5
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2007. Male patient, 57 years of age, weighting 190.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5466830-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 17, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abasia, abscess
, asthenia, convulsion, disease progression, fall , pulmonary mass. Bevacizumab dosage: 805MG IV EVERY 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, PROTONIX, SYNTHROID, ASPIRIN, KEPPRA, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5477706-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, disease progression, fall
, hemiparesis, hypotension, lung neoplasm, pneumonia , tachycardia. Bevacizumab dosage: 805MG IV EVERY 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, PROTONIX, SYNTHROID, ASPIRIN, KEPPRA, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6032679-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 07, 2009. Male patient, 55 years of age, weighting 164.0 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 744MG Q 2WKS IV. During the same period patient was treated with TEMOZOLOMIDE, ZOFRAN, ZETTIA, LIPITOR, NORVASC, DEXAMETHASONE, DILANTIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5935684-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 29, 2008. Male patient, 45 years of age, weighting 175.3 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, disease progression, pain
. Bevacizumab dosage: 810MG Q2WKS IV. During the same period patient was treated with TEMOZOLOMIDE, PRINIVIL, FIORICET, DARVON, FLEXERIL. Patient died on 05/09/2008.Bevacizumab Side Effects Report #5201340-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 27, 2006. Female patient, 41 years of age, weighting 145.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebrovascular accident, convulsion. Bevacizumab dosage: unknown. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5216295-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Female patient, 41 years of age, weighting 145.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: unknown. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5366334-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 41 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia
, confusional state, convulsion, headache , herpes simplex , muscular weakness, nuclear magnetic resonance imaging brain abnormal, vision blurred. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, PAXIL, PROTONIX, DEXAMETHASONE, DILANTIN, LIPITOR, AMBIEN, ZITHROMAX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5323521-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Female patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, headache
, hyperglycaemia, ill-defined disorder, leukopenia, paraesthesia. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, KEPPRA, NEXIUM, SENOKOT, ELAVIL, RITALIN, VALIUM, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5463066-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, atelectasis, convulsion, deep vein thrombosis
, impaired gastric emptying. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, DEXAMETHASONE, LUNESTA, TYLENOL, POTASSIUM CHLORIDE, LASIX, VYTORIN, TOPROL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5500001-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 18, 2007. Male patient, weighting 179.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 800 MG, Q2W. Patient recovered.
Bevacizumab Side Effects Report #5513722-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2007. Male patient, weighting 141.1 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: altered state of consciousness, convulsion, haemorrhagic stroke, hypertension, ischaemic stroke, nuclear magnetic resonance imaging brain abnormal, pyrexia. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, LISINOPRIL, MINOCYCLINE, ATIVAN, MARINOL, TYLENOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5793191-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 26, 2008. Female patient, weighting 199.7 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 906MG Q 2 WEEKS 4/16,30,5/14,28 IV. During the same period patient was treated with TEMODAR, KEPPRA, NEXIUM, CALCIUM, VITAMIN D, TYLENOL ES, ATIVAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5834106-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 21, 2008. Male patient, weighting 179.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 800 MG, Q2W. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6032682-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 07, 2009. Female patient, weighting 199.7 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 891MG Q2 WKS IV. During the same period patient was treated with IRINOTECAN, TEMODAR, KEPPRA, NEXIUM, ZOFRAN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5710199-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 11, 2008. Male patient, 50 years of age, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: unknown. During the same period patient was treated with ENZASTAURIN, LANTUS, LAMICTAL, BENAZEPRIL HYDROCHLORIDE, LYRICA, NEXIUM, TOPROL, NEURONTIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5793392-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 20, 2008. Male patient, 50 years of age, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: unknown. During the same period patient was treated with ENZASTAURIN, LANTUS, LAMICTAL, BENAZEPRIL HYDROCHLORIDE, LYRICA, NEXIUM, TOPROL, NEURONTIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5808454-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 10, 2008. Male patient, 50 years of age, weighting 196.2 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: amnesia, atelectasis, bacteria urine identified, chills, confusional state, convulsion, fall
, lung infiltration, nausea . Bevacizumab dosage: unknown. During the same period patient was treated with BORTEZOMIB, OMNICEF, MS CONTIN, VICODIN, DILANTIN, DECADRON, ZESTRIL, NEXIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5996103-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2008. Male patient, 47 years of age, weighting 189.4 lb, was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, PAXIL, VICODIN, IMODIUM, ZOFRAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5511903-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 25, 2007. Male patient was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 920 MG, UNK. During the same period patient was treated with CETUXIMAB, IRINOTECAN, LAMICTAL, MEDROL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5526063-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 25, 2007. Male patient was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 920 MG, UNK. During the same period patient was treated with CETUXIMAB, IRINOTECAN, LAMICTAL, MEDROL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5812184-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 10, 2008. Male patient was diagnosed with glioblastoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with ENZASTAURIN, LANTUS, LAMICTAL, BENAZEPRIL HYDROCHLORIDE, LYRICA, NEXIUM, TOPROL, NEURONTIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5814025-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 09, 2008. Male patient, weighting 196.2 lb, was diagnosed with glioblastoma, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, nausea , pyrexia, spinal fracture. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with BORTEZOMIB, OMNICEF, MS CONTIN, VICODIN, DILANTIN, DECADRON, ZESTRIL, NEXIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5515276-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 29, 2007. Male patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 1100 MG, Q2W. During the same period patient was treated with ERLOTINIB, PANTOPRAZOLE, ACETAMINOPHEN. Patient was hospitalized. Patient died on 10/06/2007.
Bevacizumab Side Effects Report #5528967-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 15, 2007. Male patient was diagnosed with gastrointestinal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 1100 MG, Q2W. During the same period patient was treated with ERLOTINIB, PANTOPRAZOLE, ACETAMINOPHEN, ZYRTEC. Patient was hospitalized. Patient died on 10/06/2007.
Bevacizumab Side Effects Report #5390564-6
Bevacizumab side effect was reported by a Physician from AUSTRALIA on July 03, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE, RISEDRONIC ACID, FERRO, PLAVIX, IRBESARTAN AND HYDROCHLOROTHIAZIDE, SPIRIVA, LIPITOR, CITRACAL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5402762-3
Bevacizumab side effect was reported by a Physician from AUSTRALIA on July 20, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE, RISEDRONIC ACID, FERRO, PLAVIX, IRBESARTAN AND HYDROCHLOROTHIAZIDE, SPIRIVA, LIPITOR, CITRACAL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5689227-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 24, 2008. Male patient, weighting 185.2 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 400 MG, 2/WEEK. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, FOLINIC ACID, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4723935-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 14, 2005. Male patient, 58 years of age, weighting 158.5 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, convulsion, thrombocytopenia. Bevacizumab dosage: 10 MG/M2, Q14D. During the same period patient was treated with OXALIPLATIN, XELODA, OXYCONTIN, OXYCODONE, DEPAKOTE, LAMICTAL, WELLBUTRIN, ZOFRAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4779615-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 21, 2005. Male patient, 58 years of age, weighting 158.5 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, convulsion, thrombocytopenia. Bevacizumab dosage: 10 MG/M2, Q14D, UNK. During the same period patient was treated with OXALIPLATIN, XELODA, OXYCONTIN, OXYCODONE, DEPAKOTE, LAMICTAL, WELLBUTRIN, ZOFRAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4823341-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 25, 2005. Male patient, 58 years of age, weighting 158.5 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, convulsion, thrombocytopenia. Bevacizumab dosage: 10 MG/M2, Q14D,. During the same period patient was treated with OXALIPLATIN, XELODA, OXYCONTIN, OXYCODONE, DEPAKOTE, LAMICTAL, WELLBUTRIN, ZOFRAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6138741-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 27, 2009. Male patient, weighting 202.8 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, hypertension, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 687.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, RAMIPRIL, BISOPROLOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5952427-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 05, 2008. Female patient, weighting 83.99 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion. Bevacizumab dosage: 390 MG/KG, UNK. During the same period patient was treated with FULVESTRANT. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6014741-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Dec 08, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, febrile neutropenia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE, METOPROLOL TARTRATE, LEVOTHYROXINE, PANTOZOL, ANAFRANIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5704435-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 11, 2008. Male patient, 65 years of age, weighting 242.5 lb, was diagnosed with anaplastic astrocytoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, delusion, hallucination, auditory, hallucination, olfactory, mania, mental status changes, psychotic disorder
. Bevacizumab dosage: 10MG/KG QOW. During the same period patient was treated with TARCEVA, NEXIUM, TOPROL, DIOVAN, LEXAPRO, PROSCAR, ORETIC, KEPPRA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5826835-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 29, 2008. Male patient, 30 years of age, weighting 149.9 lb, was diagnosed with anaplastic astrocytoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, depressed level of consciousness, mobility decreased, muscular weakness, speech disorder. Bevacizumab dosage: 10MG/KG QOW CYCLE 4:. During the same period patient was treated with ERLOTINIB, CEPHALEXIN, ACIPHEX, SENOKOT, CONCERTA, DIOVAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5340657-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on May 14, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, hypertension. Bevacizumab dosage: unknown. During the same period patient was treated with SUNITINIB MALATE. Patient recovered.
Bevacizumab Side Effects Report #5351453-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 30, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: convulsion, hypertension. Bevacizumab dosage: unknown. During the same period patient was treated with SUNITINIB MALATE, ALLOPURINOL, ASCORBIC ACID, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, CALCIUM SUPPLEMENT, ESOMEPRAZOLE MAGNESIUM, FEXOFENADINE, LEVOTHYROXINE. Patient recovered.
Bevacizumab Side Effects Report #5672383-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 11, 2008. Male patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, cardio-respiratory arrest, convulsion, hiccups, peritonitis, respiratory failure, sepsis , vomiting. Bevacizumab dosage: 5 MG/KG, Q2W. Patient was hospitalized and became disabled. Patient died on 10/20/2007.Bevacizumab Side Effects Report #5704572-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2008. Female patient, weighting 155.6 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, convulsion. Bevacizumab dosage: 352 MG. Patient was hospitalized. Patient died on 04/09/2008.